Novo Nordisk to terminate research collaboration and license agreement with Korro Bio effective Feb 1, 2027

Novo Nordisk will terminate its research collaboration and license agreement with Korro Bio, effective February 1, 2027.

Detected & updated continuously · Source: Nebula

Story subjects

Novo NordiskKorro Bio, Inc.

Track sentiment and mindshare across stocks and crypto in Nebula.

Open Nebula